CAH - Cardinal Health, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

CAH

CARDINAL HEALTH, INC.

NYSE

$247.18

▼ DOWN 0.58% (-1.43)

KEY STATISTICS

Market Cap$57.88 B

52w High$258.30

52w Low$145.87

Dividend Yield0.89%

FrequencyQuarterly

P/E23.70

Volume1.54M

Shares Out.234.21M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Jason Hollar

COMPENSATION 2026

Salary$1,492,329

Stock Awards$13,431,441

Incentive Plan Pay$3,551,742

All Other Comp.$500,683

Total$18,976,195

ABOUT

SECTOR

Healthcare

WENT PUBLIC

August 4, 1983

METHOD OF GOING PUBLIC

N/A

FULL TIME EMPLOYEES

61,344

PRICE TARGET

Target High$292.00

Target Low$250.00

Target Median$275.00

Target Consensus$273.22

UPCOMING EARNINGS

DateOct 29, 2026

DayThursday

Rev. Est.$66.71B

OCT

THU

SPLIT RECORD

DATE	TYPE	RATIO
2001-04-23	Forward	3:2
1998-11-02	Forward	3:2
1996-12-17	Forward	3:2
1994-07-01	Forward	5:4
1991-10-01	Forward	5:4
1990-10-01	Forward	5:4
1989-10-02	Forward	5:4
1988-09-09	Forward	11:10
1987-09-09	Forward	11:10
1986-02-25	Forward	11:10

PRICE

$247.18 ▼ DOWN 0.58% (−$1.43)

OVERLAYS

About Cardinal Health, Inc.

https://www.cardinalhealth.com ↗

Cardinal Health, Inc. is a global healthcare company providing customized pharmaceutical and medical products, services, and supply chain solutions to hospitals, pharmacies, and healthcare providers.

INDUSTRY

Medical - Distribution

A PRODUCT CARDINAL HEALTH, INC. IS KNOWN FOR

Kendall DL™ Multi System

A single-patient use monitoring system that continuously tracks cardiac activity, blood oxygen, and temperature via one connection, enhancing clinician workflow, ensuring reliable data, and minimizing cross-contamination risk.

COMPETITORS

COMPETITOR

Revenue by Products

PRODUCT	Q4-2025	Q2-2026	Q3-2026	Q4-2026
Pharmaceutical Member	$55.37B	$60.67B ▲	$56.11B ▼	$118.05B ▲
GMPD	$3.2B	$3.26B ▲	$3.15B ▼	$6.31B ▲
Other Operating Segment	$1.61B	$1.72B ▲	$1.71B ▼	$3.36B ▲